with a great success in eradicating S. aureus infections. 6 For first time, the emergence of methicillin-resistant strains of S. aureus (MRSA) strains as major challenges for antibiotic therapy were reported in 1961 from United Kingdom. 7 Resistance to methicillin and other derivatives is due to the acquisition of mecA gene, part of the staphylococcal cassette chromosome mecA (SCCmecA) gene cluster, which encodes a unique penicillin-binding protein (PBP2a) with reduced affinity for many β-lactams. 8 Increased resistance of MRSA to many classes of antibiotics has been frequently reported. Several antibiotics have been recommended to treat the infection. Various antibiotics alone or in combination have been used to treat the different clinical syndromes caused by MRSA. The most common antibiotics that have been prescribed against MRSA are trimethoprimsulfamethoxazole, clindamycin, glycopeptide and lipopeptide antibiotics such as vancomycin, teicoplanin and daptomycin, lipoglycopeptide antibiotics such as telavancin, dalbavancin and oritavancin, oxazolidines including linezolid and tedizolid, new cephalosporines such as ceftaroline and ceftobiprole, and glycylcyclines such as tigecycline, combination of quinupristindalfopristin and finally fosfomycin. 9 Employing of a successful and accurate empiric therapy is accomplished based on the results of antibiotic susceptibility testing; hence determination of antibiotic resistance pattern is a continuous need. In this study, we evaluated the prevalence and antibiotic resistance pattern of MRSA isolates obtained from nasal cavity of clinical staffs in Amir-Al-Momenin hospital of Zabol.
Materials and Methods
Participants A total of 277 HCWs from Amir-al-Momenin Hospital of Zabol, Southeast of Iran volunteered to participate in this study which was conducted from March to September 2017. Gender and employment information were collected.
Sample Collection
The samples were obtained from the anterior part of both nasal cavities using sterile cotton swabs, and immediately transferred to Amies transport medium (HiMedia, Mumbai, India). The samples were then sent to a bacteriology laboratory (Zabol University of Medical Sciences, Research Laboratory Center) and kept at room temperature. All the samples were separately streaked on Mannitol Salt agar (Merck, Germany) plates and incubated at 37°C for 24 hours. Suspected colonies were confirmed as S. aureus by gram staining, colony morphology and some biochemical tests such as catalase, coagulase and DNase.
Antibiotic Susceptibility Testing
All the isolates were tested for antibiotic susceptibility by disk diffusion method as recommended by the Clinical and Laboratory Standards Institute (CLSI). 10 The antibiotic disks (MAST, UK) used in susceptibility testing included ciprofloxacin (5 µg), gentamycin (10 µg), tetracycline (30 µg), clindamycin (2 µg), meropenem (10µg), ertapenem (10 µg), linezolid (30 µg), erythromycin (15 µg), rifampin (5 µg) and vancomycin (30 µg). S. aureus ATCC 25923 was used as the quality control strain.
Identification of MRSA Strains
Methicillin resistance was preliminary assessed by agar dilution method in the Muller-Hinton agar with 4% NaCl and 6 µg/mL oxacillin as described by the CLSI. 10 Then, MRSA strains were confirmed by detection of mecA using polymerase chain reaction (PCR) according to a previously described method. 11 S. aureus ATCC ® 29213 and S. aureus ATCC ® 43300 were used as the quality control strains.
Statistical Analysis
Data was analyzed by the SPSS version 16 (Chicago, USA) using chi-square test. P value ≤ 0.05 was considered significance level.
Results
The . The frequency of nasal carrier of S. aureus was significantly different between men (46.7%) and women (53.3%) (P = 0.018). Fourteen (46.7%) isolates were found to be MRSA. The distribution of MRSA isolates was not significantly different in different wards of the hospital (Table 1) (P = 0.109) and between men and women (P = 1.000).
All the isolates were susceptible to vancomycin and gentamicin. Meanwhile, all MSSA isolates were susceptible to gentamycin, meropenem and ertapenem ( Table 2) .
Three MRSA isolates were resistant to at least three different classes of antibiotics that were classified as MDR. 12
Discussion
To the best of our knowledge, this is the first comprehensive report of the nasal carriage of S. aureus from the city of Zabol. Frequency of nasal carriage in our study was 10.8% with significantly higher prevalence in women. This frequency is lower than those obtained in the previous studies. 3, [13] [14] [15] Meanwhile, our findings revealed that 46.7% of the isolates were MRSA, which is in agreement with the study of Dadashi et al (43.0%). 16 It has been noted that the prevalence of MRSA has increased from the year 2000, which partly explains the high prevalence of MRSA observed in our study.
There are several factors that may explain these inconsistencies, the most important of which include sample size, culture techniques, limited infrastructure, and lack of sufficient knowledge regarding transmission routes. 15 Widespread distribution of MRSA among HCWs in Iran may be due to several reasons such as lack of a regular screening program for most important causative pathogens of hospital-acquired infections like MRSA, inefficient MRSA management and finally indiscriminate use of antibiotics. 16 Our results showed low resistance to ciprofloxacin (7.1%) and surprisingly no resistance to gentamycin, linezolid, rifampin and vancomycin among MRSA isolates. Similarly, full susceptibility of MRSA isolates to vancomycin, linezolid and rifampin has already been reported. 17, 18 The lack of resistance to gentamycin observed in our study is somehow consistent with very low resistance level reported by other researchers 13, 19 ; however, this observation may also be attributed to limited use of injectable antibiotics such as gentamycin in HCWs or even patients.
Our findings showed that the highest frequency of resistance was against erythromycin (64.3%) that is similar to some other studies. [19] [20] [21] Moderate resistance to new carbapenem antibiotics like meropenem and ertapenem was observed among MRSA isolates in our study, which is supported by some studies reporting ineffective activity of these antibiotics alone against MRSA strains. 22, 23 Therefore, administration of carbapenems in combination with other antibiotics is recommended to produce synergistic effects.
The varied resistance rates reported from different regions may be because of the fact that most significant bacterial pathogens like MRSA are disseminated from different clones in different regions. Therefore, various resistance patterns of bacterial isolates obtained from different regions are likely. 24 Furthermore, some resistance markers could be acquired from environment or be created in consequence of mutations. Thus, different resistance patterns for a bacterial pathogen could be reported from different regions. Therefore, empirical therapy of MRSA infection is a precise and difficult procedure that may widely differ in different regions of the world. 
Conclusion
In conclusion, precise detection of antibiotic resistance patterns and eradication of bacterial pathogens are essential to prevent MRSA epidemics in hospital settings. Based on our findings, the low rates of resistance to gentamycin, ciprofloxacin and rifampin indicate that these antibiotics can be used to eradicate MRSA. A regular screening protocol is required to accurately evaluate the epidemiology of S. aureus nasal carriage and determine the prevalence of MRSA isolates.
